Lehrstuhl für Innere Medizin IV

Podocyte density and albuminuria in aging diabetic ins2± mice with or without adenosine a1 receptor signaling (2020) Faulhaber-Walter R, Jiang L, Mizel D, Zerfas PM, Kopp JB, Schnermann JB, Chen L, Schiffer M Journal article Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design (2020) Böhm M, Townsend RR, Kario K, Kandzari D, Mahfoud F, Weber MA, Schmieder R, et al. Journal article Renal sympathetic nerve activity regulates cardiovascular energy expenditure in rats fed high salt (2020) Morisawa N, Kitada K, Fujisawa Y, Nakano D, Yamazaki D, Kobuchi S, Li L, et al. Journal article Renal Chemerin Expression is Induced in Models of Hypertensive Nephropathy and Glomerulonephritis and Correlates with Markers of Inflammation and Fibrosis (2019) Mocker A, Hilgers KF, Cordasic N, Wachtveitl R, Menendez-Castro C, Wölfle J, Hartner A, Fahlbusch F Journal article Characterizing renal involvement in Hermansky-Pudlak Syndrome in a zebrafish model (2019) Schenk H, Mueller-Deile J, Schroder P, Bolanos-Palmieri P, Beverly-Staggs L, White R, Braesen JH, et al. Journal article New data, new studies, new hopes for renal denervation in patients with uncontrolled hypertension (2019) Papademetriou V, Stavropoulos K, Imprialos K, Doumas M, Schmieder R, Pathak A, Tsioufis C Journal article, Review article Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry (2019) Mahfoud F, Böhm M, Schmieder R, Narkiewicz K, Ewen S, Ruilope L, Schlaich M, et al. Journal article Tuberculous granulomatous interstitial nephritis in a renal allograft (2019) Schmidt-Lauber C, Büttner-Herold M, Schiffer M, Wiesener MS Journal article Reduction in blood pressure following renal denervation for patients with differing baseline cardiovascular risk (2019) Mahfoud F, Mancia G, Schmieder R, Narkiewicz K, Ruilope L, Schlaich M, Williams B, et al. Conference contribution Combined therapy of empagliflozin and linagliptin is superior to metformin and insulin glargine in improving blood pressure and vascular function in type 2 diabetes (2019) Jung S, Bosch A, Kannenkeril D, Karg M, Striepe K, Bramlage P, Ott C, Schmieder R Conference contribution